Fraunhofer-Gesellschaft

Publica

Hier finden Sie wissenschaftliche Publikationen aus den Fraunhofer-Instituten.
2020Canakinumab for Treatment of Adult-Onset Still's Disease to Achieve Reduction of Arthritic Manifestation (CONSIDER): Phase II, randomised, double-blind, placebo-controlled, multicentre, investigator-initiated trial
Kedor, C.; Listing, J.; Zernicke, J.; Weiß, A.; Behrens, F.; Blank, N.; Henes, J.C.; Kekow, J.; Rubbert-Roth, A.; Schulze-Koops, H.; Seipelt, E.; Specker, C.; Feist, E.
Zeitschriftenaufsatz
2019Canakinumab For The Treatment Of Adult Onset Still's Disease To Achieve Reduction Of Arthritic Manifestation At Week 12: An Investigator-Initiated Multi-Centre, Placebo-Controlled Study (Consider)
Kedor, C.; Listing, J.; Zernicke, J.; Weiss, A.; Behrens, F.; Blank, N.; Henes, J.; Kekow, J.; Rubbert-Roth, A.; Schulze-Koops, H.; Seipelt, E.; Specker, C.; Feist, E.
Abstract
2019Efficacy Of Etanercept Over A Period Of 12 Months In The Routine Treatment Of Patients With RA, AxSpA, PsA Or Pso: Final Results Of A German Non-Interventional, Prospective, Multi-Center Study (Adequate)
Feist, E.; Baraliakos, X.; Behrens, F.; Thaci, D.; Klopsch, T.; Plenske, A.; Blindzellner, L.K.; Meng, T.; Löschmann, P.A.
Abstract
2018Abatacept used in combination with non-methotrexate disease-modifying antirheumatic drugs
Alten, R.; Burkhardt, H.; Feist, E.; Krüger, K.; Rech, J.; Rubbert-Roth, A.; Voll, R.E.; Elbez, Y.; Rauch, C.
Zeitschriftenaufsatz
2017Impact of rituximab in combination with leflunomide and rituximab retreatment with two different dosages on patient-reported outcomes: results from a multicenter randomized placebo controlled investigator initiated clinical trial in active rheumatoid arthritis (AMARA-STUDY)
Köhm, M.; Rossmanith, T.; Dauth, S.; Alten, R.; Aringer, M.; Backhaus, M.; Burmester, G.; Feist, E.; Kellner, H.; Krüger, K.; Müller-Ladner, U.; Rubbert-Roth, A.; Tony, H.P.; Wassenberg, S.; Burkhardt, H.; Behrens, F.
Abstract
2016Effectiveness of Different Dosages of Retreatment of Rituximab in Combination with Leflunomide: Results from a Multicenter Randomized Placebo Controlled Investigator Initiated Clinical Trial in Active Rheumatoid Arthritis (Amara-Study
Behrens, F.; Rossmanith, T.; Koehm, M.; Alten, R.; Aringer, M.; Burmester, G.R.; Feist, E.; Krüger, K.; Müller-Ladner, U.; Rubbert-Roth, A.; Wassenberg, S.; Tony, H.P.; Kellner, H.; Backhaus, M.; Burkhardt, H.
Abstract
2016Rituximab in combination with leflunomide: Results from a multicenter randomized placebo controlled investigator initiated clinical trial in active rheumatoid arthritis (Amara-Study)
Behrens, F.; Rossmanith, T.; Köhm, M.; Alten, R.; Aringer, M.; Backhaus, M.; Baerwald, C.; Burmester, G.; Feist, E.; Kellner, H.; Krüger, K.; Müller-Ladner, U.; Rubbert-Roth, A.; Tony, H.P.; Wassenberg, S.; Burkhardt, H.
Abstract